He thought it was gout. Doctors said he needed hospice. A clinical trial saved his life.
A Florida man diagnosed with terminal acute myeloid leukemia was saved after a clinical trial provided an alternative treatment when standard chemotherapy failed. His story highlights the critical role of experimental medicine in treating aggressive, treatment-resistant cancers.
Why it matters
It underscores the life-saving potential of clinical trials for patients who have exhausted standard medical options.
Ryan Goepel knew he didn't always treat his gout as well as he should. The inflammatory condition can be triggered by diet and lifestyle factors, and flare-ups can cause pain and discomfort.When the Florida father of three's knee started hurting during a trip in September 2024, Goepel thought it was just one of those flares. But when the ache didn't go away, he went to his doctor. She gave him some medication, and took blood to run tests. Two days later, she called with alarming results."She said, 'Stop whatever you're doing, and go straight to the hospital.' And I'm like, 'What do you mean?'" Goepel recalled. "She says, 'Just go. You have no immune system. I don't know what's wrong. Just go.'"Goepel rushed to a nearby sports medicine hospital, where he underwent another round of blood work.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in